Actualités Osmotica Pharmaceuticals PLC - OSMT | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Quarterly Report (10-q)

0.0783489900626781300000-00000008329756783515411000.080.220.080.15--12-312022Q10001739426false0001739426us-gaap:MeasurementInputExpectedTermMemberu...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14AProxy Statement Pursuant to Section 14(a...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14AProxy Statement Pursuant to Section 14(a...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2022-04-06 2022-04-06 iso4217:USD...

Annual Report (10-k)

1.281.470.270.161.011.3100000000-000000062545832832975670P1Y00P30DP3Y6M2021FY0001739426false0001739426rvlp:Senio...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2022-03-30 2022-03-30 iso4217:USD...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

-- Fourth Quarter 2021 net sales for UPNEEQ grew by approximately 41% to $3.1 million compared to the third...

Current Report Filing (8-k)

0001739426 false 00-0000000 0001739426 2022-01-19 2022-01-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Osmotica Pharmaceuticals PLC (OSMT)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

OSMT Actualités

Additional Proxy Soliciting Materials (definitive) (defa14a)

Statement of Changes in Beneficial Ownership (4)